Jason Norris

New Valence Robotics Corp. provides automated three-dimensional 3D printing solutions. Its products include hardware, software and materials. The firm solutions include business, education and resellers. The company was founded by AJ Perez, Forrest Pieper, Mateo Peña Doll and Chris Haid and is headquartered in Boston, MA.

Lapix Therapeutics, Inc. is a company located in the US that is focused on developing new therapies for autoimmune diseases and oncology. The American company's approach involves creating orally bioavailable immune system restoration therapies that are designed to be effective and easy to use.

Elektrofi, Inc. operates as a biotechnology company that focuses on drug formulation innovations. The firm offers revolutionary protein formulations, high-tech processing and modern applications and value across the healthcare ecosystem. The company was founded by Chase Coffman and Jason Norris in 2016 and is headquartered in Boston, MA.

Mytide Therapeutics, Inc. is a peptide and biopolymer manufacturing and computational biology company based in Massachusetts. Mytide's focus is on eliminating the time-consuming and labor-intensive chemical and screening processes that prevent innovative therapeutics from reaching the clinic. The American company's quick-turn manufacturing technology, combined with AI-enabled predictive analytics, provides access to a novel peptide space for the discovery and therapeutic manufacturing of difficult-to-make natural and non-natural peptide and peptide conjugates. The company was founded by Dale Thomas and has been led by CEO Martina Diekmann since 2023.

Mytide Therapeutics, Inc. is a peptide and biopolymer manufacturing and computational biology company based in Massachusetts. Mytide's focus is on eliminating the time-consuming and labor-intensive chemical and screening processes that prevent innovative therapeutics from reaching the clinic. The American company's quick-turn manufacturing technology, combined with AI-enabled predictive analytics, provides access to a novel peptide space for the discovery and therapeutic manufacturing of difficult-to-make natural and non-natural peptide and peptide conjugates. The company was founded by Dale Thomas and has been led by CEO Martina Diekmann since 2023.